Rankings
▼
Calendar
NUVB FY 2023 Earnings — Nuvation Bio Inc. Revenue & Financial Results | Market Cap Arena
NUVB
Nuvation Bio Inc.
$2B
FY 2023 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$100M
Net Income
-$76M
EPS (Diluted)
$-0.35
Cash Flow
Operating Cash Flow
-$68M
Free Cash Flow
-$68M
Stock-Based Comp.
$20M
Balance Sheet
Total Assets
$621M
Total Liabilities
$16M
Stockholders' Equity
$605M
Cash & Equivalents
$43M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
$0
—
Operating Income
-$100M
-$120M
+16.6%
Net Income
-$76M
-$104M
+27.3%
← Q4 2022
All Quarters
Q1 2023 →